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RNAse A misma/ch cleavage analysis of 66 primary human colon /umours reveals a high inciden ce of K-ras genes with 
mutations at posi/ion 12. No apparent correlation was found between the presence of mutant oncogenes and the degree of 
invasiveness of the tumours but evidence for ras mutational activa/ion in premalignant tissue was obtained. 
INCREASING evidence indicates that the products of ceHular 
proto-oncogenes are involved in the regulation of ceH growth 
in both normal and pathological tissue l. The ras genes and their 
products are among the best studied of the ceHular oncogenes. 
The highly conserved ras gene family encodes c\osely re\ated 
proteins (p21"') which are localized in the plasma membrane, 
bind guanine nuc\eotides and exhibit weak GTPase activitl-s. 
Jt is thought that ras proteins are involved in the process of 
signal transduction across the ceH membranc9 • lo . 
Three members of the mammalian ras gene family (c-K-ras, 
c-H-ras and N-ras )11-16 acquire oncogenic activity in cultured 
established ceH Iines by somatic mutations resulting in the 
substitution of single amino acids at particular positions in the 
p21 proteins l7 - D 
The role of ras oncogenes in mammalian tumorigenesis has 
been well documented in various carcinogen-induced animal 
tumour model systems24 - 2k • The carcinogen-specific and repro-
ducible activation of ras oncogenes observed in them provides 
strong evidence that the activation by somatic mutation of ras 
oncogenes is involved in initiation of carcinogenesis. Similar 
studies are not possible in humans. Although activated ras 
oncogenes have been found in a significant percentage ofhuman 
tumours (see refs lO, 29 and 30 for reviews), it has not been 
demonstrated that ras oncogene activation causes pathogenesis 
of human cancer. In contrast with the frequent, reproducible, 
and therefore predictable, mutational activation of ras 
oncogenes in sorne animal model systems, the incidence of 
mutant ras oncogenes in human tumours is difficult to assess 
with the available information !o. 
We have recently developed a new method for detecting and 
cha'racterizing single base substitutions in transcribed genes, 
based on the ability of RNAse Ato recognize and c\eave single-
base mismatches in RNA . RNA duplexes31 • Total ceHular RNA 
is hybridized to homogeneously labelled, antisense RN A 
molecules synthesized with the SP6 in viera transcription sys-
tem32 • Digestion with RNAse A c\eaves the labeHed RNA probe 
into fragments of defined size that can be analysed by gel 
electrophoresis. Because the size ofthese fragments is dependent 
on the position of the mismatches in the RNA duplexes, the 
mutations can be localized in the gene transcripts. In addition, 
this method can be used to estimate the expression levels of 
both normal and mutant alleles in the same cell, even when they 
differ by only a single nuc\eotide31 • 
We have applied the RNAse A mismatch c\eavage method to 
the diagnostic detection of point mutations in the first coding 
exon of the c-K-ras gene in a large panel of primary human 
colon tumours. Mutant genes at codon 12 were present and 
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expressed in about 40% of these tumours whereas mutations at 
other positions of the first coding exon were not detected. No 
apparent correlation was found between the presence of mutant 
oncogenes and the stage of progression of the tumours. A high 
frequency of ras oncogenes was detected in premalignant villous 
adenomas and in carcinomas originating in villous adenomas. 
The simultaneous presence of c-K-ras and N-ras oncogenes 
was found in a colon adenocarcinoma and in a pre-invasive 
villous adenoma. 
K-ras oncogenes in colon tumours 
Total ceHular RNA- was prepared from frozen tumours and 
hybridized to an antisense RNA pro be complementary to the 
coding strand of the first coding exon of the c-K-ras proto-
oncogene. The hybridized RNA was digested with RNAse A 
and analysed by denaturing polyacrylamide gel electrophoresis 
(PAGE). The RNA probe that we have used spans most of the 
c-K-ras first coding exon, from the Sau3A si te to the 5' splicing 
acceptor site (Iocated at nucleotide positions + 1 02 and -11 
relative to the AUG initiation codon, respectively) and about 
180 additional nucleotides of upstream intron sequences31 . 
Hybridization of this antisense RNA probe to mature normal 
c-K-ras mRNA followed by digestion with RNAse A generates 
a protected RNA duplex of 114 base pairs (bp). When this RNA 
probe is annealed to c-K-ras transcripts with single base substi-
tutions at codon 12, the RNA duplexes contain single base 
mismatches (Table 1) that when c1eaved by the enzyme will 
generate smaller RNA fragments. 
Typical results are shown in Fig. 1. RNA from T24 bladder 
carcinoma ceH line which contains a mutant c-H-ras 
oncogene17•18 , as well as RNA from tumours 5 and 11 (Fig. la) 
and 27 (Fig. 1 b), yielded only a major band of 114 nuc\eotides 
(nt) representing the full-Iength protected RNA fragment. RNA 
from PR371 lung carcinoma ceH line which contains a c-K-ras 
oncogene with a cysteine mutation at codon 12 (ref. 23 and 
Table 1), yielded bands of 46 and 67 nt diagnostic of a mis match 
at this position in the c-K-ras transcripts. These bands were also 
present when RNA from tumours 3,7 and 22 (Fig. la), and 22, 
10,25,28 and 23 (Fig. lb), were hybridized to the RNA probe 
and digested with RNAse A, indicating the presence of mutant 
c-K-ras genes at codon 12 in these tumours. 
Fragments of the c-K-ras genes from tumours 3 and 28 were 
c\oned and their first coding exons were sequenced. These 
experiments confirmed the presence of point mutations in the 
c-K-ras gene from these tumours, which were characterized as 
cysteine (TGT) and serine (AGT) substitutions at codon 12 
(Table 1), respectively (urtpublished). These results demonstrate 
the applicabilityof the RNAse A mismatch cleavage method 
for the diagnostic detection in primary tumours of ras genes 
containing single point mutations. 
TIte sensitivity of the RNAse A method for detecting single 
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Fig. 1 RNAse A mismatch c1eavage analysis of coK-ras tran-
scripts from human colon tumours. Total cellular RNA from the 
tumours and tumour cell lines indicated at the top were hybridized 
to radioactively labelled antisense RNA corresponding to the first 
coding exon of the coK-ras proto-oncogene (lOs c.p.m.) for 16 h 
at 50 oc. Hybridized RNAs were digested at 30 oC with RNAse A 
(4Q¡¡.gml- l ) for 10 and 60min (from left to right) (a) or at 35°C 
with 75 ~g ml- I of enzyme for 90 min (b) and electrophoresed 
through denaturing polyacrylamide gels. Amounts of RNA used 
ranged from 20 to 80 ~g. Lane marked tRN A, only carrier transfer 
RNA was used during hybridization. Numbers at left (a) or right 
(b), indicate the position and size (in nt) of HaellI (MI) or Hinn 
(M!l) restriction fragments of ~ x 174 DNA used as size markers. 
Complete arrows indicate the position and size (in nt) of the RNA 
fragments generated by RNAse A cleavage at the mismatch of 
codon 12. Halfarrows indicate the position and size ofthe protected 
RNA fragments corresponding to the first coding exon. 
P: undigested RNA probe. 
Methods. RNA was prepared from cultured cells or from frozen 
tumors (0.2-1 g) by the guanidine HCI method as described31 . 
Quality of RNAs was tested by formaldehyde-agarose gel s and 
staining with ethidium bromide. Only samples of tumour RNA 
showing the presence of ribosomal 285 and 185 RN A stained bands 
at approximate ratios of 2: 1 were used. Radioactive RNA probes 
were synthesized using 1 ¡¡OS of linearized pAKIN§ly (ref. 31) with 
tbe SP6 polymerase in vitro transcription system3 as described31 • 
Hybridizations and RNAse A disestions were as described" usinS 
lel purified RNA probes33 • RNA samples were analysed by poll.-
acrylamide sel electropboresis and autoradiography as described l. 
b~e substitutions depends on the efficiency of cleavage at the 
mlsmatch by the enzyme3J •33 • Thus, whereas the mismatches 
present in RNA hybrids of some tumour RNAs were readily 
cleaved by RNAse A (Fig. la), an increase in the di¡cstion time 
and temperature, and enzyme concentration, was required to 
obtain siJllificant cleavage of other samples (Fig. lb). These 
conditions also increased the background bands due to non-
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Amino acids encoded by the normal (Gly) and mutant codo n 12 of 
the human c-K-rCll gene and the corresponding nuc1eotide sequence of 
the sene transcripts (reading 5' ... 3') are indicated at the topo Nuc1eotide 
sequences of the 12th codon in antisense RNA (reading 3' -+ 5') corre-
sponding to the normal or mutant coK-ras transcripts are shown paired 
tothe codon 12 rnRNAsequences. Perfectly paired RNA· RNAduplexes 
are indicated by circles. AH single or double mismatches are boxed. 
Hatched boxes represent mismatches recognized and c1eaved by RNAse 
A (ref. 31 and C.A., K.F. and M.P., unpublished data). Empty boxes, 
mismatches that have not been analysed. Double box, the G- U mismatch 
that is not recognized by the enzyme. 
specific cleavage by RNAse A of perfectly matched RNA 
duplexes, especíally in A + U-rich regions. 
We took advantage of the finding that the G-U mismatch 
generated by hybridizatíon of normal coK-ras transcripts with 
the antísense RNA probe corresponding 10 the gene with a 
serine mutation al codon 12 (Table 1) is not c1eaved by RNAse A 
under the standard conditions of digestion. This is not surprising 
because these bases can pair in RNA' RNA duplexes34 • However, 
coK-ras transcripts with mutations at the second posítion of 
codon 12 generate RNA hybrids containing a double mismatch 
when hybridized with the serine RNA probe: the G- U mismatch 
at the first posítion and another mismatch (A-C, U-C or C-C) 
at the second position of Ihe triplet (Table 1). These double 
mismatches are now recognized and cleaved by the enzyme very 
efficiently. 
Mutation frequency of K-ras 
We screened colon tumours for the presence of mutant coK-ras 
genes by hybridizing their RNAs to the serine RNA probe and 
digesting the resulting hybrids with RNAse A (Fig.2). RNA 
from normal human fibroblasts (HNF) and tumours 2, 14, 9, 
12,41,30,27 and 17 (Fig. 2a) and 4, 6, 8,19,29,31,32,33,36, 
38 and 39 (Fig. 2b) yíelded only a major protected RNA frag-
ment of 114 nucleotides (together with other minor nonspecific 
bands). RNA from tumours 20, 21, 23, 1,25 and 40 (Fig. 2a) 
and 18, 24, 26, 40, 34, 35, 37 and 42 (Fig. 2b), yielded the 66-
and 46-nt bands diagnostic ofthe presence of CoK-ras transcripts 
with mutations at the second base of codon 12. RNA from 
SK-CO-1 colon carcinoma cell line, which contains a CoK-ras 
gene with a valine mutation (Table 1) at codon 12 (C.A., K.F. 
and M.P., manuscript in preparation), and from PR371 (Fig. 2b) 
was also cleaved, yielding the codon 12 mismatch-diaJllostic 
bands. A faint band of about 300 nt was present in most cases 
(indicated .. 'un' in Fig_ 2b), representin¡ tbe WIIpliced CoK-ras 
tranacripta (absence of thi, band in lOme sampl • .". .. probably 
due to degradation of the RNAs). This band .".81 also eleaved 
in the positive samples, yielding a sub-band of about 230 nt 
(indicated as '.' in Fig. 2b). 
Fil. 2 Analysis of e·K·ras transcripts mutant 
at the second base of codon 12. Total cellular 
RNA from tumours and eell lines indicated at 
the top were hybridized to 32 P·labelled anli· 
sense RNA (105 C.p. m.) directed by pAKI Mser, 
for 12 h at 50·C. Hybridized RNAs were 
digested at 30·C (a) or 25·C (b) for 60 min 
and analysed in denaturing polyacrylamide 
gels. Amounts of RNA ranged from lO to 45 Ilg. 
Symbols in b: un, unspliced transcript; ., 
deavage product of the unspliced transcript. 
Other symbols are as in Fig. 1. 
Methods. A plasmid directing the synthesis of 
antisense RN A containing a serine mutation at 
codon 12 ofthe c·K·ras gene (pAKIMser) was 
constructed by subdoning into the pGEM·4 
vector the Sau3A- Pst! 280·base pair frag· 
ment of the c·K·ras gene isolated from colon 
tumour 28. 
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The results obtained with a series of 66 primary human colon 
tumours are summarized in Table 2. Twenty.six samples were 
positive in the RNAse A mismatch cleavage assay. Of those, 8 
were characterized as point mutations at the first base and 18 
at the second base of codon 12, by comparing their cleavage 
pattems with the normal and mutant RNA probes. 
In contrast with the high frequency of mutant c·K·ras genes 
(39%) observed with the RNAse A mis match cleavage method, 
only 20% (6 of 30) of the tumours that we have analysed were 
seo red as positive in the NIH 3T3 focus formation assay 
(Table 2). 
K-ras expression 
Our studies also provided information on the express ion levels 
of both normal and mutant c·K·ras alleles in human colon 
tumours. No clear difierences were observed in the express ion 
levels of the c·K.ras gene in difierent tumours, regardless of 
the presence or absence of mutations at codon 12. Comparison 
of the c·K·ras gene expression levels in neoplastic and normal 
tissue from the same individual also failed to reveal significant 
differences (data not shown). 
Analysis of the relative expression of mutant and normal 
aUeles in primary tumours was complicated by the presence of 
varying amounts of contaminating normal tissue in the tumour 
samples and by incomplete e1eavage of sorne of the mismatches. 
However, the efficient e1eavage of the double mismatch genero 
ated by hybridization of the c·K·ras transcripts with the serine 
RNA probe allowed an approximate estimate of the relative 
expression of c·K·ras genes containing mutations at the second 
position of codon 12 (Fig.2). In most cases, the expression 
level~ o~ muta.n~ and normal alleles were similar (compare the 
relatlve 10tenslbes of protec:t~d and e1eaved radioactive bands). 
SK·CO-l .RNA used as ~oslbve control was apparently e1eaved 
more eftictentiy because 10 these cells the mutant transcripts are 
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two· to threefold more abundant than the normal transcripts 
(C.A., K.F. and M.P., in preparation). 
K-ras and tumour progression 
Analysis of the data of Table 2 reveals several features. No 
apparent correlation was found between the presence or absence 
of mutant c·K·ras genes and the age, sex or race of the cancer 
patients, or the anatomicallocalization ofthe tumours, support· 
ing the somatic nature of ras gene mutational activation. In this 
context, in a1\ ten cases that we have analysed, no mutations in 
the first coding exon of the c·K.ras gene were found in normal 
colon tissue adjacent to tumours positive for mutant oncogenes 
by the RNAse A mismatch e1eavage assay (data not shown). 
No significant differences were found between the mutation 
frequency at position 12 of the c·K·ras gene and the degree of 
difierentiation or stage of progression of the tumours. Mutant 
genes were found in tumours ranging from early stages of 
progression to very advanced stages of disease (Table 2). 
However, a striking difference was apparent between the posi. 
tion of the mutations at codon 12 of the c-K·ras gene and the 
degree of invasiveness of the tumours. Whereas 4 of the 8 
mutations at the first position of codon 12 (NGT) were present 
in the gene of tumours at early stage of progression (grades O 
and A), 16 of the 18 mutations at the second position of the 
triplet (G NT) were present in the gene of more invasive tumours 
(grades B, C and D) (Table 2). Further studies will be necessary 
to determine the significance of these differences and their 
possible prognostic value in human colon cancer. 
NU ODcogenes In premallgDant tumoun 
In terms of the histological features of the tumours, a strikingly 
high incidence of mutant c-K·ras oncogenes was found in 
tumours originating in villous adenomas and villoglandular 
pOlyps. These are relatively common types of benign tumours 
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Fle. 3 RNAse A mismatch c1eavage analysis of coK-ras tran-
scripts from villous adenoma 28. RNA (30 ¡.¡.g) prepared from two 
difierent portions of the same tumour (TI and TII) as well as 60 ... g 
of RNA prepared from normal colon tissue from the same 
individual (N) were hybridized to 32P-labelled antisense RNA 
corresponding 10 the normal c·K-ras first coding exon. The hybrids 
were digested with RNAse A at 30 oC for 30 and 90 min (shown 
from left to right) and analysed in a denaturing polyacrylamide 
gel as before, RNA from the SK-CO·¡ cel1 line (30 ¡.¡.g) was al so 
analysed in parallel as positive control. Symbols are as in Fig, 1. 
which emerge directly from the colonic mucosa as large 
superficial neoplasms and which develop malignant properties 
more frequently than do adenomatous polyps. Thus, these types 
of benign tumours often contain focal areas of conversion to 
carcinoma. However, such tumours are only considered malig-
nant when infiltrating activity can be demonstrated by micro· 
scopic analysis 35 
Of the eight colon tumours originating in villous adenomas 
that we have analysed, seven contained coK-ras genes mutant 
at the first coding exon, five at the first base of codon 12 and 
two at the second (Table 2). Interestingly, the only tumour which 
was scored as negative in the RNAse mismatch c1eavage method 
(tumour 50) was positive in the NIH 3T3 focus assay (Table 2), 
suggesting the presence of another ras oncogene or of a coK-ras 
gene with a mutation at another position. 
These eight tumours were collected at difierent stages of 
progression. Tumour 31 was metastatic at time of surgery (grade 
e), tumours 42 and 50 had already perforated the colon wall 
(grade B) and tumours 43 and 58 had infiltrated the muscularis 
propia (grade A), Tumours 60, 3 and 28 were obtained at very 
early stages of development. Histological analysis of tumour 60 
revealed a villoglandular polyp containing multiple small foci 
of well-difierentiated adenocarcinoma which were superficial 
with no evidence of stalk invasion. Tumour 3 was c1assified as 
a moderately difierentiated adenocarcinoma, arising within a 
villous adenoma but the carcinoma did not invade beyond the 
submucosal layer. Histopathological analysis of tumour 28 
revealed a villous adenoma with focal areas of carcinoma in 
si/u (no invasion) and was accordingly classified as a premalig-
nant villous adenoma. 
Fragments of frozen tissue from these last two tumours (3 
and 28) were resubmitted for microscopic analysis. A fragment 
oftumour 3 adjacent to the tissue used for both DNA and RNA 
preparations contained only villous adenoma tissue. Two addi-
tional distinct fragments of tumour 28 (fragments I and 11) were 
similarly analysed. Whereas fragment I contained -10-20% of 
carcinoma in si/u, fragment 11 contained only villous adenoma 
tissue. 80th fragments contained normal colon tissue in propor-
tions varying from lOto 30%. 
Coexistence of K-ras and N-ras oncogenes 
Tumour 28 was initially found to contain a mutated coK-ras 
gene by the RN Ase A cleavage method (Fig. 1 b). Parallel analy-
sis of the transforming activity of DNA from this tumour in the 
NIH 3T3 focus formation assay revealed the presence of a 
transforming gene which was identified by Southem blotting of 
NIH 3T3 primary transformants as the N-ras oncogene (data 
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not shown). However, subsequent c10ning and sequence analysis 
confirmed a serine mutation at codon 12 of the coK-ras gene 
present in the same tumour DNA preparation that yielded N-ras 
NIH 3T3 transformants. 
Repeated analyses by the RNAse A mismatch c\eavage 
method (Fig. 3) and the NIH 3T3 focus assay (data not shown) 
with difierent fragments of the same frozen tumour immediately 
adjacent to the fragments 1 and II previously submitted for 
microscopic characterization confirmed the simuJtaneous pres-
ence of activated N-ras and coK-ras oncogenes in preinvasive 
villous adenoma 28. Similar results were obtained with tumour 
37, which contained a mutant coK-ras oncogene as detected by 
the RNAse mismatch c\eavage method (Fig. 2) and an activated 
N-ras oncogene as detected by the focus fonnation assay (Table 
2 and data not shown). 
Discussion 
We have used a new method for the diagnostic detection of 
single point mutations in transcribed genes to study the 
frequency of coK-ras oncogenes in a series of primary human 
colon tumours. Our results show that the association of somatic 
mutations at codon 12 of the coK-ras gene with this type of 
human cancer is significantly higher than previously estimated 
using the NIH 3T3 transfection assaylO. The explanation for this 
difierence most probably lies in the sensitivity of these methods. 
The NI H 3T3 focus fonnation assay is particularly insensitive 
in the detection of activated coK-ras genes due to the large size 
of this IOCUS 21 •23 • In agreement with these results, DNA of sorne 
tumours containing mutant coK-ras genes failed to induce foei 
in NIH 3T3 cells despite their ability to transfer in parallel 
experiments the human thymidine kinase gene (Table 2). Owing 
to the limitations in the sensitivity of our method and considering 
that we have not analysed other regions of the coK-ras gene36, 
or the other two characterized human ras oncogenes, our esti-
mate that 40% of human colon carcinomas contain activated 
ras oncogenes may be conservative, 
The RNAse A mismatch cleavage method, unlike the oligonu-
cleotide hybridization procedure27 ,37-40, is not limited to a 
defined localization ofthe point mutations in the gene. However, 
we have not found mutations in the first coding exon of the 
coK-ras gene at positions other than codon 12. This result argues 
against the hypothesis that mutations in ras genes are a secon-
dary consequence of the intrinsically high mutation rate of 
cancer cells with no direct association with the tumorigenesis 
process41 • 
Taking into account the presence of contaminating normal 
tissue in the tumour samples, the information obtained on the 
expression levels of coK-ras genes mutant at the second position 
of codon 12 suggests that the mutant allele was present and 
expressed in most of the tumour cells in most of the positive 
samples. These results support the concept that mutational acti-
vation of ras genes is directly involved in tumour progression 
by conferring a selective growth advantage on the cells in which 
it occurs10,29,30. At the same time, the apparent presence and 
expression of the normal allele in these tumours suggest that 
10ss of the normal allele is not a prerequisite for tumour 
development. 
Although our findings on the mutational activation of the 
coK-ras gene in tumours 3 and 60 and of the coK-ras and N-ras 
genes in villous adenoma 28 do not exclude the possibility that 
the mutations in these genes may have occurred after the conver-
sion from adenoma to carcinoma or to focal carcinoma in situ, 
we consider this possibility unlikely. Repeated microscopic 
examinations indicated that if carcinoma cells were present in 
the tumour samples that we used for preparation of DNA and 
RNA. their relative proportion was no greater than 10-20%. 
Unless the mutant ras alleles has undergone considerable 
amplification in these ceUs, it is unlikely that they could have 
been so readily isolated from genomic libraries and detected by 
the RNAse A mismatch method and the NIH 3T3 focus assay. 
I 
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ThereCore, we interpret these results a~ indicati~e that ras muta-
tional activation has already occurre~ 10 t.he bemgn tumour c~lls. 
It is tempting to suggest a parallehsm 10 ras oncogene actlva-
tion between our results with human colon villous 
adenomas/carcinomas and the initiation/promotion experi-
mental system of mouse skin papillomas/ carcinomas24.28.42. In 
tbiuystcm, topical application ofthe carcinogen DMBA (7,12-
dimetbylbenzanthracene) induces the mutational activation of 
the c-H-ras gene which may give rise to the benign skin papil-
lomas arter treatment wilh lumour promoters. Sorne of these 
papillomas undergo further alterations and progress to malig-
nant carcinomas. 
The high frequency of mutant CoK-ras genes thal we have 
found in villous adenomas and in colon carcinomas originating 
in villous adenomas suggestS that ras somatic mutational activa-
tion is also involved in the development of these benign human 
tumours. However, the simultaneous presence of both coK-ras 
and N-ras oncogenes in villous adenoma 28 and in adenocar-
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Possible relation between the X-ray QPO 
phenomenon and general relativity 
Bohdan Paczyóski 
Princeton University Observatory, Princeton University, 
Princeton, New Jersey 08544, USA 
Many bright X-ray sourees "ere recently (ound to undergo quasi-
periodie oscillationsl4• None oC tbe sourees is an X-ray pulsar 
"hicb indicates tbat the aeereting neutron stan have no magnetos-
pheres. Most neutron star models have radli smaller than 35ehwar-
lIdlild radil5,Between 69% and 868/.0( the accretion energy is 
lIberated "hen matter falls from the marginally stable orbit "itb 
a ra4ius r M. = 3rSch onto tbe neutron star surface6 • The accretion 
tIow through r _ is kno"n to be compllcate4, .nd a steady-state 
ft.,.. lDay not be possible "ben tbe viscosity parameter a > a .. ::::: 
0.03',8. Here I sunest that tbe uosteady ftOw "ould make the 
tioIIlldary-layer lumioosity variable, ])OSSibly living rise to the 
X-fay quasl-periodie oscillatloll (QPO) phenomenon. 
Thin disk accretion onto a black bol e Was a malter for many 
theoretical studies, w'ith a c1assic paper written by Novíkov and 
lbome9 _ TIte disk accretion is subsonic, !he streamlines are 
almost identical with the keplerian orbits bt!yond tbe marginally 
stable omit, r> r m .. and matter falls freely into the black hole 
at r <: r ms' Some insight into the character of accretion ftow near 
' .... was provided by the theory ofthiek accretion disksIO,\l. Near 
the marginally stable orbil the radial velocity of accreting matter 
changes from subsonic for r> rros to supersonie for r < rms ' The 
sonic radíus is slightly smaller than r ms in thick disks, as well 
as in thin disks with a« 112-14. 
Muchotrzeb7 noticed that the ftow in thin accretion disks is 
complicated for a> a er = 0.03, In fact she could not find station-
ary solutions in this case. Subsequenl studies revealed that while 
the critical (sonie) poinr of the flow was of a saddle type for 
a < a cr and imposed a reslriction on the ftow, for a> a.r the 
critical point was of a nodal Iype, and did not impose any 
restiction on the flOW 8,15. As a result there was a continuum of 
steady-state solutions for a large viscosity: the location of the 
sonic point was free to vary over a small but finite range of 
radii. Muchotrzeb8 suggested lhat the ftow was unstable for 
a> acr. . 
Physical inlerpretation of the mathematical properties of 
accretion flow near rms for a> a", remains unclear. Suppose 
that the viscosity is very small and very gradually removes 
angular momentum from a given ring of matter, The matter will 
find its new, nearly keplerian orbit, corresponding to its new 
angular momentum, At r = r m. keplerian orbits have a minimum 
ofangular momentum, and orbits with r<: rnu are dynamically 
unstable. Therefore, a quasistatic disk cannot exist for r <: r n:u' 
a well-known result. This phenomenon is related to general 
relativity, a consequence oC a strong gravitational field. In the 
low-viscosity case, matter is pushed across r"" by a small but 
finite radial pressure gradiant. The situation is similar lo !he 
Roche lobe overflow. 
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